Retraction: Exploring the therapeutic potential of IL-17A inhibition in myasthenia gravis: a retrospective study on secukinumab

BMJ Neurology Open 2026 Open access

Read full text
DOI: 10.1136/bmjno-2025-001249ret
Cited by: 0
References: 2

Abstract

[This retracts the article DOI: 10.1136/bmjno-2025-001249.].

Fields of Study & Subjects

Myasthenia Gravis and Thymoma Inflammatory Myopathies and Dermatomyositis Peripheral Neuropathies and Disorders

Publication details

Journal / source
BMJ Neurology Open
Volume
8
Issue
1
Pages
e001249ret–e001249ret
Publication date
1 March 2026
Language
EN